Last Updated : April 20, 2023
Details
Project Line:
Reimbursement Review
Project Sub Line:
Pharmaceutical Review Update
Refer to Pharmaceutical Reviews Update ― Issue 36 for important news and information regarding the Canada's Drug Agency drug review programs. Highlights from this issue include:
-
clarification on wording within Procedures for Canada's Drug Agency Reimbursement Reviews.
Canada's Drug Agency Program Updates
1.Clarification on Wording Within Procedures for Canada's Drug Agency Reimbursement Reviews
Canada's Drug Agency has revised the Procedures for Canada's Drug Agency Reimbursement Reviews (Sections 1.2.1 and 6.4.1) to add clarification on the objectives of the drug review process. Revisions have also been made within Appendix 2 in response to recommendations from the procedural review panel, to provide further clarity and guidance for those who wish to make a request for a procedural review or who are considering doing so.
If you have questions regarding the revised schedule, please contact [email protected].
Last Updated : April 20, 2023